Patricia Amé-Thomas - T follicular helper cells in follicular lymphoma : one of the most important players in the malignant B cell niche
Key | Action |
---|---|
K or space | Play / Pause |
M | Mute / Unmute |
C | Select next subtitles |
A | Select next audio track |
V | Show slide in full page or toggle automatic source change |
left arrow | Seek 5s backward |
right arrow | Seek 5s forward |
shift + left arrow or J | Seek 10s backward |
shift + right arrow or L | Seek 10s forward |
control + left arrow | Seek 60s backward |
control + right arrow | Seek 60s forward |
shift + down arrow | Decrease volume |
shift + up arrow | Increase volume |
shift + comma | Decrease playback rate |
shift + dot or shift + semicolon | Increase playback rate |
end | Seek to end |
beginning | Seek to beginning |
Informations sur ce média
Nombre de vues :
4Date de création :
mai 12, 2016Lien vers la chaîne du média :
Autres videosDescription
Follicular lymphoma (FL) is the most frequent indolent lymphoma and results from the malignant transformation of germinal centre B cells in secondary lymphoid organs. Beside the genetic alterations associated with the deregulation of the anti-apoptotic protein Bcl2, the growth of malignant FL B cells relies on the development of a supportive microenvironment, which forms a specialized cell niche contributing to disease development, progression, and drug resistance. Immunohistochemistry studies showed that malignant FL B cells are found admixed to specific stromal and immune cell subsets, in particular CD4+ T cells. In addition, some of these reports studying the expression of a unique T-cell marker revealed that more than their absolute number, the nature and the localization of T cells were associated with prognosis. This suggests that different functional CD4+ T cell subsets could play an important role in FL pathogenesis.Based on this hypothesis, we decided to explore by multi-color flow cytometry the CD4+ T cell compartment found in close contact with FL B cells in malignant lymph nodes.We demonstrated that CD4+ T cells localized in malignant follicles by their high expression of CXCR5 merged two distinct populations: a PD1+ ICOS+ CD25+ FOXP3+ T follicular regulatory cell subset (Tfr) and a PD1+ ICOS+ CD25- FOXP3- T follicular helper cell subset (Tfh). Using functional experiments on sorted T-cell subsets, we demonstrated that Tfr cells were able to inhibit the proliferation of effector T cells and were devoid of FL B-cell supportive effect. In addition, we revealed that tumor-infiltrating Tfh cells displayed a specific cytokine secretion profile, and had a supportive effect on malignant FL B cell growth. Finally, after a deeper characterization of this FL-Tfh compartment, we revealed that CD10+ FL-Tfh cells exhibited an IL-4hi IFN-low cytokine profile compared to their CD10neg counterpart, associated with a better capacity to sustain malignant FL B-cell survival. Interestingly, we found that the specific stroma network was involved in the capacity of Tfh cells to highly synthetize IL-4. Overall, these observations revealed that CD4+ T cells in contact with malignant FL B cells have a more heterogeneous phenotype than previously assumed, and are fully involved in the maintenance of the tumor. These CD4+ T cell subsets emerge as a central therapeutic target, and evaluation of the proportion of these cells would be useful to better predict the biological effect of new drugs.
2nd IGO meeting
La seconde édition des conférences organisées par le Labex IGO (IGO meeting) s’est déroulée les 21 et 22 avril 2016 à la Faculté de pharmacie de Nantes. Cette conférence a rassemblé 160 spécialistes de l’immunologie, de la transplantation et de l’oncologie. Des orateurs français et étrangers (USA, Grande-Bretagne, Pays-Bas, Espagne, Italie, Suisse) sont venus exposer leurs travaux et les dernières avancées dans leurs domaines de recherche. Des sessions (communications orales et posters) étaient également réservées aux jeunes chercheurs pour qu’ils puissent présenter leurs travaux et ainsi favoriser les échanges avec leurs collègues et les chercheurs séniors. Ce 2nd IGO meeting, en créant un environnement propice à l’initiation de nouvelles collaborations à l’intérieur et au-delà du périmètre du Labex IGO, a été un vrai succès scientifique.
Autres médias dans la chaîne "Autres videos"
- 53 vues, 1 ce moisConsultation et laboratoire de génétique20 juillet 2023
- 5 vues, 1 ce moisProjet Estuaire (laboratoires IREENA, LTeN)24 janvier 2023
- 30 vues, 2 ce moisInstitut des substances et organismes de la mer - ISOMER12 juillet 2022
- 262 vues, 1 ce mois3 questions à... Catherine de Charette, directrice de la Fondation Nantes Université27 juin 2022
- 1346 vues, 1 ce moisÉlections Nantes Université - 3 questions à Carine Bernault17 décembre 2021
- 71 vues, 1 ce moisLe point sur les élections avec Marc Renner, administrateur provisoire de Nantes Université4 novembre 2021